IA
EBS icon

Icon Advisers’s Emergent Biosolutions EBS Stock Holding History

Icon Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,500
Closed -$1.68M – 372
2017
Q3 		$1.68M Hold
41,500
– – 0.12% 205
2017
Q2 		$1.41M Buy
+41,500
New +$1.28M 0.1% 244
2016
Q4 		– Sell
-30,000
Closed -$946K – 420
2016
Q3 		$946K Buy
+30,000
New +$872K 0.06% 307
2015
Q1 		– Sell
-228,968
Closed -$6.23M – 346
2014
Q4 		$6.23M Sell
228,968
-29,510
-11% -$703K 0.37% 86
2014
Q3 		$5.51M Buy
258,478
+69,300
+37% +$1.59M 0.32% 93
2014
Q2 		$4.25M Buy
189,178
+125,478
+197% +$2.92M 0.27% 87
2014
Q1 		$1.61M Buy
+63,700
New +$1.61M 0.12% 155

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Icon Advisers's EBS Position: Q4 2017 in Review

Icon Advisers sold out of Emergent Biosolutions (EBS) in Q4 2017, closing a stake of 41,500 shares — an estimated $1.68M sold.

Icon Advisers first reported a position in EBS in Q1 2014 and held it in 7 quarters. The position peaked at $6.23M in Q4 2014. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • Icon Advisers reported no remaining Emergent Biosolutions position as of Q4 2017 after selling out during the quarter.
  • Icon Advisers sold 41,500 Emergent Biosolutions shares in Q4 2017, an estimated $1.68M.
  • Icon Advisers first reported a position in Emergent Biosolutions in Q1 2014 and held it in 7 quarters.
  • Icon Advisers's Emergent Biosolutions position peaked at $6.23M in Q4 2014.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on Icon Advisers's 13F filing for Q4 2017, filed 6 Feb 2018.